TITLE

Rare side effect of vaccination

PUB. DATE
November 1997
SOURCE
CMAJ: Canadian Medical Association Journal;11/15/97, Vol. 157 Issue 10, p1340
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports from United States researchers on the loss of hair after routine vaccinations. The cases mostly involving women; The hepatitis B vaccine most involved; The possible rare side effect of vaccination.
ACCESSION #
9711160661

 

Related Articles

  • A most dangerous medical mandate? Howd, Aimee // Insight on the News;06/21/99, Vol. 15 Issue 23, p48 

    Discusses the adverse effects of the hepatitis B vaccine inoculation on children. Autoimmune and neurological illness; Reported number of deaths and injuries after inoculation; Attempts of parents to stop United States legislators from mandating federal recommendations that every baby be...

  • Hepatitis B vaccine recombinant.  // Reactions Weekly;Mar2014, Vol. 1493 Issue 1, p26 

    The article presents a case study of an 4-day-old male neonate who developed isolated abducens nerve palsy after receiving the hepatitis B vaccine recombinant.

  • More on Vaccinations. Gerson, Charlotte // Gerson Healing Newsletter;Jan/Feb2010, Vol. 25 Issue 1, p5 

    The author discusses the dangers of childhood vaccinations. She mentions the forced vaccination of schoolchildren in Prince George's County, Maryland. She discusses a greater risk of autism spectrum disorder in children vaccinated for Hepatitis B. She notes the lack of rigorous studies into the...

  • Hepatitis A vaccine.  // Reactions Weekly;1/16/2010, Issue 1284, p26 

    The article presents the case of a 6-year-old girl who developed erythema multiforme after she received three doses of the hepatitis A vaccine. The patient presented with generalized pruritic rash a day after she received the third dose of the vaccine. She was treated with prednisone and...

  • Hepatitis B vaccine recombinant.  // Reactions Weekly;3/22/2008, Issue 1194/1195, p20 

    The article describes a case of recombinant Hepatitis B vaccine-induced pruritus and swelling. It references a study by D. G. Ebo and colleagues, published in the April 2008 issue of "Allergy." The patient, an older woman, received the same vaccine previously without any site reaction. To...

  • Travel Immunizations. Lo Re III, Vincent; Gluckman, Stephen J. // American Family Physician;7/1/2004, Vol. 70 Issue 1, p89 

    Advising travelers on vaccine-preventable illnesses is increasingly becoming the responsibility of primary care physicians. The approach to vaccine recommendations should be based on a thorough assessment of the risks for travel-related diseases, the time available before and current knowledge...

  • Hepatitis B vaccine recombinant.  // Reactions Weekly;2/17/2007, Issue 1139, p14 

    The article presents a case study of a 5-year-old boy who developed a slightly pruritic skin eruption on his face and limbs 3 weeks after a first dose of recombinant hepatitis B vaccine. A biopsy of the boy's skin showed acanthosis, hyperkeratosis, lymphocytic exocytosis, spongiosis in the...

  • Hepatitis A vaccine.  // Reactions Weekly;6/2/2007, Issue 1154, p15 

    The article presents a case report of Gianotti-Crosti syndrome in a child. Three days after receiving the hepatitis A vaccine a boy developed a pruritic skin eruption. The boy was referred to a Dermatology Department four weeks after vaccination. He was given oral antihistamines and his skin...

  • Efficacy and safety of a vaccine against human leptospirosis in Cuba. Martínez, Raydel; Pérez, Alberto; Quiñones, María del C.; Cruz, Raúl; Álvarez, Ángel; Armesto, Marlén; Fernández, Carmen; Menéndez, Jorge; Rodríguez, Islay; Baró, Morelia; Díaz, Manuel; Rodríguez, José; Sierra, Gustavo; Obregón, Ana Margarita; Toledo, María Eugenia; Fernández, Norma // Revista Panamericana de Salud Publica;Apr2004, Vol. 15 Issue 4, p249 

    Objectives. To evaluate the efficacy of vax-SPIRAL, a Cuban vaccine against leptospirosis, and to provide additional information concerning the safety of this vaccine (which was developed by Cuba's Finlay Institute). Methods. This phase III efficacy trial of vax-SPIRAL was controlled,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics